Blueprint Medicines Corporation (NASDAQ:BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, is hosting its first R&D Day in New York...

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, the unique proprietary bioactive composition made from fertilized...

DaVita Clinical Research (DCR) is set to present 10 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week in...

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases,...

Hyster-Yale Materials Handling, Inc. (NYSE:HY) announced today that it will hold an Analyst Day for institutional investors and equity analysts on Tuesday, November 19th, starting at 8:15 am EST...